Journal of Experimental Medicine

The Journal of Experimental Medicine is a peer-reviewed academic journal published by the Rockefeller University Press that publishes research papers and commentaries on the physiological, pathological, and molecular mechanisms that encompass the host response to disease. The journal prioritizes studies on intact organisms and has made a commitment to publishing studies on human subjects. Topics covered include immunology, inflammation, infectious disease, hematopoiesisas, cancer, stem cells and vascular biology. The JEM is second highest (based on impact factor) among the journals that publish basic research articles from all fields of biomedicine. Among all biomedical journals (specialized or nonspecialized) JEM stands among the top 10. The JEM was founded in 1896 at the Johns Hopkins School of Medicine by William H. Welch, the school’s founder and also the first president of the Board of Scientific Directors of the Rockefeller Institute (since re-named the Rockefeller University). From its inception, Welch edited the journal by himself—even editing manuscripts while attending baseball games—and he eventually found that it placed too heavy a burden on his time. By March 1902, the

Publisher
Rockefeller University Press
Country
United States
History
1896–present
Website
http://www.jem.org/
Impact factor
14.776 (2010)

Some content from Wikipedia, licensed under CC BY-SA

Cardiology

Attacking aortic aneurysms before they grow

A new study investigates a genetic culprit behind abdominal aortic aneurysm, a serious condition that puts people at risk of their aorta rupturing—a potentially deadly event.

Diseases, Conditions, Syndromes

Brain disease transmitted by tick bites may be treatable

Tick-borne encephalitis is a disease just as nasty as it sounds. Once bitten by an infected tick, some people develop flu-like symptoms that resolve quietly but leave behind rampant neurological disease—brain swelling, ...

Medical research

Chemotherapy with fewer side effects may be on the way

A discovery by University of Queensland pain researchers may allow some future cancer patients, including children with leukemia, to avoid their chemotherapy's worst and most debilitating side effects.

Medical research

How bone marrow regenerates after chemotherapy

Chemotherapy has a damaging effect on hematopoietic stem and progenitor cells (HSPCs) in bone marrow. However, once chemotherapy ends, HSPCs regenerate, a process that has remained unknown—until now. In a new study, researchers ...

page 1 from 39